Prasterone (dehydroepiandrosterone) for intravaginal Treatment of Hypoactive Sexual Desire Disorder Female, Female sexual arousal disorder, disorder of the Female Orgasm and Female sexual arousal disorder interest in women who are not suffering from symptoms of atrophy vulvovagin The dyspareunia and / or moderate to severe； product that understands.
Intravaginal DHEA is used for the treatment of at least one condition selected from the group consisting of female hypoactive sexual desire disorder, female sexual arousal disorder, female orgasm disorder and female sexual interest arousal disorder in a woman who either (1) is not suffering from symptoms of vulvo-vaginal atrophy and/or (2) is not suffering from moderate to severe dyspareunia.USO DE PRASTERONA (DHEA) PARA PREPARAR UN MEDICAMENTO ÚTIL PARA TRATAR AL MENOS UNA CONDICIÓN SELECCIONADA DEL GRUPO QUE CONSISTE EN TRASTORNO HIPOACTIVO DEL DESEO SEXUAL FEMENINO, TRASTORNO DE LA EXCITACIÓN SEXUAL FEMENINA, TRASTORNO DEL ORGASMO FEMENINO Y TRASTORNO DE LA EXCITACIÓN INTERÉS SEXUAL FEMENINO.
